We practice at the convergence of life sciences, healthcare, and technology, serving as a destination firm for innovators, leaders, and investors across the industry. We are a mission-driven team that works collaboratively across practice groups in the United States, Europe, and Asia. We have vigilantly built, protected, and enforced many landmark portfolios in the industry today, playing a critical role in precedent-setting, high-stakes litigation. Clients turn to us because we bring in the right subject matter experts to counsel across the full product lifecycle, understanding issues from the earliest stages of research and development to market leadership and continued growth. Our work cuts across all practice areas, including venture capital financing, IP strategy and litigation, strategic collaborations and licensing, FDA regulatory compliance and enforcement, corporate M&A and transactions, and privacy and data security.
Our science and patent experience is unmatched, with backgrounds in antibodies, biologics, biosimilars, small molecules, cell and gene therapies, genomics, immunotherapies, medicinal chemistry, vaccines, and more.
Our team is uniquely positioned to address the next generation of legal and regulatory issues that medtech companies face in response to the emerging application of software, artificial intelligence, and machine learning. With our deep roots in science and technology, we craft strategic legal strategies for our clients as new medical technology continuously evolves to improve patient care.